Circulating Tumor Cells in Non-Small Cell Lung Carcinoma — LDx  

Primary Lung Cancer Clinical Trial

Official title: Phase 2 Study of Circulating Tumor Cell in Non-Small Cell Lung Carcinoma

Status Completed

Clinical Trial Summary

The purpose of this study is to establish the circulating tumor cell (CTC) assay as a surrogate for tissue diagnosis of suspected primary lung cancer. This is done through evaluating clinical and molecular markers to stratify the outcome/survival in patients with thoracic malignancies treated at Yale University/Yale-New Haven Hospital, University of California San Diego/Moores Cancer Center, Billings Clinic Cancer Center.

Clinical Trial Description

n/a

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

• Carcinoma, Non-Small-Cell Lung
• Lung Neoplasms
• Neoplastic Cells, Circulating
• Primary Lung Cancer

• NCT number: NCT01830426
• Study type: Observational
• Source: Epic Sciences
• Status: Completed
• Phase: N/A
• Start date: November 2012
• Completion date: January 2016